Health Sorafenib Plus SBRT Improves Survival in Advanced HCC Eli Pacheco Feb 24, 2023 0 In this exclusive roundtable video from MedPage Today, three expert leaders in the field of…
Health Elevar Therapeutics Announces Camrelizumab Plus Rivoceranib Significantly Prolonged… Eli Pacheco Sep 8, 2022 0 Top-line findings will be presented Sept. 10 at the annual European Society for Medical Oncology (ESMO) Congress This is the first positive pivotal trial to show survival benefits with a…
Health Clinical Challenges: Maintenance Therapy for AML Eli Pacheco May 11, 2022 0 New drug combinations and better supportive care have led to improved outcomes in patients with acute myeloid leukemia (AML). However,…
Health Clinical Challenges: FLT3 Inhibitors After Allo-Transplant in AML Eli Pacheco Jan 7, 2022 0 Relapse after allogeneic hematopoietic cell transplantation (HCT) in acute myeloid leukemia (AML) is an extremely risky clinical…